TransMedics Completes Asset Acquisition/Disposition

Ticker: TMDX · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1756262

Transmedics Group, Inc. 8-K Filing Summary
FieldDetail
CompanyTransmedics Group, Inc. (TMDX)
Form Type8-K
Filed DateOct 6, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$14.5 million
Sentimentneutral

Sentiment: neutral

Topics: acquisition, disposition, assets

TL;DR

TransMedics just closed a deal on assets. Details TBD.

AI Summary

TransMedics Group, Inc. announced the completion of an acquisition or disposition of assets on October 3, 2025. The filing does not specify the nature of the assets or the financial details of the transaction.

Why It Matters

This filing indicates a significant corporate action by TransMedics Group, Inc., potentially impacting its business operations and financial structure.

Risk Assessment

Risk Level: medium — The lack of specific details regarding the acquisition or disposition of assets introduces uncertainty about the transaction's impact.

Key Players & Entities

  • TransMedics Group, Inc. (company) — Registrant

FAQ

What specific assets were acquired or disposed of by TransMedics Group, Inc.?

The filing does not specify the nature of the assets involved in the acquisition or disposition.

What was the date of the completion of the asset transaction?

The transaction was completed on October 3, 2025.

What is the principal executive office address for TransMedics Group, Inc.?

The principal executive office is located at 200 Minuteman Road, Andover, Massachusetts 01810.

What is the SEC file number for TransMedics Group, Inc.?

The SEC file number is 001-38891.

What is the Standard Industrial Classification code for TransMedics Group, Inc.?

The SIC code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.

Filing Stats: 708 words · 3 min read · ~2 pages · Grade level 15.4 · Accepted 2025-10-06 16:15:09

Key Financial Figures

  • $14.5 million — C for a purchase price of approximately $14.5 million (together with the Prior Acquisitions,

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSMEDICS GROUP, INC. Date: October 6, 2025 By: /s/ Gerardo Hernandez Name: Gerardo Hernandez Title: Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.